Keryx Biopharmaceuticals : KERX

All KERX Articles

45 Articles

Jon C. Ogg | Sep 8, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Altria, BofA, FireEye, Ford, J.P. Morgan, Linn Energy and More

These are the top analyst upgrades and downgrades covered by 24/7 Wall St. for Monday, September 8, 2014.

Chris Lange | Sep 5, 2014 at 3:05 PM EDT

Keryx Finds Out That Not All FDA Approvals Are Great Wins

ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval from the FDA on its most recent…

Jon C. Ogg | Jan 31, 2014 at 8:55 AM EST

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

The Quantitative Strategies team at Jefferies closely monitors the index changes. 24/7 Wall St. screened the Jefferies list of stocks…

Jon C. Ogg | Jan 7, 2014 at 8:25 AM EST

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers.…

Jon C. Ogg | Nov 5, 2013 at 1:10 PM EST

Four Big Healthy Biotech Gainers, One Big Loser

ThinkstockBiotech and certain aspects of the health care and life sciences sector can often see incredible surges from day to…

Jon C. Ogg | Jun 19, 2013 at 8:05 AM EDT

Top Analyst Upgrades and Stocks to Buy: Adobe, Gevo, Keryx, Teva and More

Investors and traders are often on the hunt for fresh research ideas that will lead to higher income or more…

Jon C. Ogg | Jun 11, 2013 at 8:10 AM EDT

PropThink Biotech Stocks With Big Upside Potential

ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and…

Jon C. Ogg | May 7, 2013 at 6:50 AM EDT

Thirteen Stocks Expected to Rise 40% to 100% — or More

Investors and traders alike always seem to be on the lookout for new speculative investment ideas that can generate massive…

Jon C. Ogg | May 1, 2013 at 8:40 AM EDT

PropThink Analyst Finds Five Cheap Biotech Stocks to Buy

ThinkstockBiotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap…

Paul Ausick | Feb 1, 2013 at 4:08 PM EST

24/7 Wall St. Closing Bell — February 1, 2013: Markets Stronger on Economic Data (VZ, MA, EPD, STZ, UPS, BYI, GDOT, WYNN, CVX, XOM, MAT, MRK, NOV, TSN, CYOU, GCI, HUM, GOLD, RCL, SPG, CLX, ZTS, KERX, FB)

U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose…

Paul Ausick | Jan 29, 2013 at 4:06 PM EST

24/7 Wall St. Closing Bell — January 29, 2013: Markets Shake Off Slow Start, Post Gains (STX, TSN, SBUX, ANF, CAT, YHOO, STX, STLD, BSX, DHI, F, BTU, PFE, VLO, AMZN, BRCM, RYL, RHI, ADT, LLL, PSX, NOC, SO, KERX, VMW, OCZ)

U.S. equity markets opened slightly lower this morning following not-much in the way of new data and a wait-and-see attitude…

247sam | Jan 29, 2013 at 11:04 AM EST

Today’s Market Winners and Losers

Photo by Spencer Platt/Getty ImagesThe stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.27%, the Nasdaq…

Paul Ausick | Jan 28, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)

U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than…

Jon C. Ogg | Jan 28, 2013 at 1:56 PM EST

Keryx Gets Back on the Map

ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on…

247sam | Jan 28, 2013 at 10:23 AM EST

Today’s Market Winners and Losers

The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the…

1 2 3

Keryx Biopharmaceuticals : KERX

All KERX Articles

Top Analyst Upgrades and Downgrades: Altria, BofA, FireEye, Ford, J.P. Morgan, Linn Energy and More

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

Four Big Healthy Biotech Gainers, One Big Loser

Top Analyst Upgrades and Stocks to Buy: Adobe, Gevo, Keryx, Teva and More

PropThink Biotech Stocks With Big Upside Potential

Thirteen Stocks Expected to Rise 40% to 100% — or More

PropThink Analyst Finds Five Cheap Biotech Stocks to Buy

24/7 Wall St. Closing Bell — February 1, 2013: Markets Stronger on Economic Data (VZ, MA, EPD, STZ, UPS, BYI, GDOT, WYNN, CVX, XOM, MAT, MRK, NOV, TSN, CYOU, GCI, HUM, GOLD, RCL, SPG, CLX, ZTS, KERX, FB)

24/7 Wall St. Closing Bell — January 29, 2013: Markets Shake Off Slow Start, Post Gains (STX, TSN, SBUX, ANF, CAT, YHOO, STX, STLD, BSX, DHI, F, BTU, PFE, VLO, AMZN, BRCM, RYL, RHI, ADT, LLL, PSX, NOC, SO, KERX, VMW, OCZ)

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)

Keryx Gets Back on the Map

Today’s Market Winners and Losers

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Keryx Biopharmaceuticals : KERX

All KERX Articles

Top Analyst Upgrades and Downgrades: Altria, BofA, FireEye, Ford, J.P. Morgan, Linn Energy and More

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

Four Big Healthy Biotech Gainers, One Big Loser

Top Analyst Upgrades and Stocks to Buy: Adobe, Gevo, Keryx, Teva and More

PropThink Biotech Stocks With Big Upside Potential

Thirteen Stocks Expected to Rise 40% to 100% — or More

PropThink Analyst Finds Five Cheap Biotech Stocks to Buy

24/7 Wall St. Closing Bell — February 1, 2013: Markets Stronger on Economic Data (VZ, MA, EPD, STZ, UPS, BYI, GDOT, WYNN, CVX, XOM, MAT, MRK, NOV, TSN, CYOU, GCI, HUM, GOLD, RCL, SPG, CLX, ZTS, KERX, FB)

24/7 Wall St. Closing Bell — January 29, 2013: Markets Shake Off Slow Start, Post Gains (STX, TSN, SBUX, ANF, CAT, YHOO, STX, STLD, BSX, DHI, F, BTU, PFE, VLO, AMZN, BRCM, RYL, RHI, ADT, LLL, PSX, NOC, SO, KERX, VMW, OCZ)

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)

Keryx Gets Back on the Map

Today’s Market Winners and Losers

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not